Built by the HPERA Research Facility · AIAU Lab

Small Molecule
Biofield

A new energy field. A new frontier for molecules. Precision molecular regulation through natural forces alone — no solvents, no reagents.

Developed by the HPERA Research Facility · AIAU Lab

A new class of energy field

At the frontier of biophysics, HPERA has discovered a fundamentally new class of energy field — the Small Molecule Biofield — opening an unprecedented pathway for precise control at the molecular scale.

This discovery does not rely on chemical reagents, catalysts, or solvents. Instead, it harnesses a natural energetic phenomenon that interacts directly with molecular bonds, enabling cleavage and reformation with a fidelity that conventional chemistry cannot match.

The lab has also independently developed the world's first device capable of generating this field — the Peptides Small Molecule Field Generator (PSMFG) — translating a fundamental discovery into a working technology platform.

H₂N COOH Peptide chain synthesis within the biofield Lysozyme folding

How it works

The Small Molecule Biofield exerts a directed energetic influence at the molecular scale, enabling the precise cleavage and reformation of chemical bonds.

Within this field, molecular structures can be disassembled and reconstructed with a fidelity that conventional chemistry cannot match. The process is driven entirely by natural field forces — no synthetic intervention required.

The field operates without chemical solvents. Molecules are reshaped through natural force alone, producing clean output suitable for direct biological application.

Bond Before Biofield interaction After: reconfigured

Dark Matter & Dark Energy

The two most mysterious and dominant constituents of the universe — invisible, undetectable directly, yet governing cosmic evolution. HPERA bridges these deep cosmic forces with molecular-level biotechnological application.

Dark Matter — The Invisible Scaffolding

Dark matter neither emits nor reflects light, yet holds galaxies together through gravity. Like an invisible cosmic skeleton, it provides the structural framework upon which the visible universe is built.

85% of all matter in the cosmos

Dark Energy — The Cosmic Anti-Gravity

An even more enigmatic force, dark energy drives the accelerating expansion of the universe — behaving like a ubiquitous, all-pervading form of anti-gravity that pushes space itself apart.

68% of the universe's total energy

Neither can be seen or directly detected — yet together they govern the evolution of the universe. Understanding their nature is the core frontier of contemporary physics and cosmology.

Dark Matter Dark Energy Research

Dark Matter / Dark Energy
Peptide Synthesis

HPERA continues to push the boundaries of spatial bio-intelligence, achieving a breakthrough by introducing dark matter and dark energy into biological substrate interaction experiments.

From Cosmic Forces to Molecular Change

Within a precisely controlled experimental environment, dark matter and dark energy act as carriers of an invisible field, interacting with natural biological substrates — such as Yulong Snow Mountain rose — and inducing unprecedented structural rearrangement at the molecular level.

The introduction of dark matter and dark energy opens an entirely new dimension for life science research. HPERA explores the deep connections between matter and energy, the visible and the invisible — unlocking infinite possibilities for the creation of future bioactive materials.

Peptides Small Molecule Field Generator

Independently researched, designed, and built by HPERA, the PSMFG is the world's first device capable of generating and sustaining a Small Molecule Biofield — the convergence of frontier physics and precision engineering.

Dark matter / Dark energy Planck-scale unfolding Higher-dim Biofield output
World's First

Operating Principle

The PSMFG harnesses dark matter and dark energy, unfolding them through Planck-scale operations in higher-dimensional space to excite and generate the Small Molecule Biofield.

Within the field it produces, small-molecule peptides and lysozyme are extracted — without chemical solvents, without harming any living organism.

Dark matter / energy Higher-dimensional physics Planck-scale precision Solvent-free synthesis

Where theory meets reality

The HPERA Research Facility · AIAU Lab, where the Peptides Small Molecule Field Generator operates — bridging dark matter physics, molecular biology, and precision engineering under one roof.

HPERA Research Facility · AIAU Lab — PSMFG research facility

What the platform can do

Beyond demonstrated peptide and lysozyme synthesis, the Small Molecule Biofield enables broad molecular structure reconfiguration — a platform technology, not a single-purpose tool.

Clean chemistry

Chemical bonds broken and reconstituted through natural field forces alone. No solvents, no catalysts, no synthetic reagents — and no harm to living organisms.

Precision at scale

Molecular-level control with broad applicability — from targeted bond cleavage to full structural reconfiguration across diverse molecular species.

Biocompatible output

Products — peptides, lysozyme, and beyond — emerge in biologically compatible form, free from chemical residue or contamination.

Platform technology

Not a single-purpose tool — a foundational platform whose molecular reconfiguration capability extends across compound classes.

Why it matters

A fundamentally new modality of control at the atomic scale — solvent-free, biocompatible, and broadly applicable across industries.

Life Sciences

Precision synthesis of bioactive molecules, enzyme production, and targeted molecular therapies — all without chemical interference or contamination.

Advanced Materials

De novo design and fabrication of novel materials through molecular engineering enabled by field-driven bond reconfiguration.

New Energy

Alternative pathways for energy conversion and storage at the molecular scale, leveraging the field's unique interaction with matter.

Human Health & Wellness

A new technological foundation for the broad health industry — from bioactive supplements to regenerative applications — with solvent-free, biocompatible production.

Experimental data and performance metrics to be added — including synthesis yields, purity levels, lysozyme activity assays, bond-specific cleavage precision, and processing time comparisons versus conventional methods.

The Small Molecule Biofield is not an incremental improvement. It is a platform discovery — a new layer of nature that HPERA is the first to discover and harness, from fundamental science through to working instrumentation.